Metagenomi, Inc. - Common Stock (NQ:MGX)
Price and Volume
Detailed Quote| Volume | 355,775 |
| Open | 1.640 |
| Bid (Size) | 1.600 (1,400) |
| Ask (Size) | 1.610 (500) |
| Prev. Close | 1.600 |
| Today's Range | 1.560 - 1.640 |
| 52wk Range | 1.230 - 4.920 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Metagenomi Prioritizes Hemophilia A Program, Lays Off 25% Workforce ↗
November 12, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
November 12, 2025
These stocks are moving in today's after hours session ↗
November 11, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
November 11, 2025
Metagenomi Appoints Laurence Reid, PhD to its Board of Directors
August 11, 2025
Which stocks are gapping on Wednesday? ↗
July 09, 2025
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
February 11, 2025
Stargate, Netflix, GE Aerospace, Twilio, and More ↗
January 29, 2025
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
January 22, 2025
Frequently Asked Questions
Is Metagenomi, Inc. - Common Stock publicly traded?
Yes, Metagenomi, Inc. - Common Stock is publicly traded.
What exchange does Metagenomi, Inc. - Common Stock trade on?
Metagenomi, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metagenomi, Inc. - Common Stock?
The ticker symbol for Metagenomi, Inc. - Common Stock is MGX on the Nasdaq Stock Market
What is the current price of Metagenomi, Inc. - Common Stock?
The current price of Metagenomi, Inc. - Common Stock is 1.605
When was Metagenomi, Inc. - Common Stock last traded?
The last trade of Metagenomi, Inc. - Common Stock was at 12/02/25 02:51 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.